- United Kingdom
- /
- Healthtech
- /
- AIM:IUG
Positive Sentiment Still Eludes Intelligent Ultrasound Group plc (LON:IUG) Following 29% Share Price Slump
Intelligent Ultrasound Group plc (LON:IUG) shares have retraced a considerable 29% in the last month, reversing a fair amount of their solid recent performance. Instead of being rewarded, shareholders who have already held through the last twelve months are now sitting on a 21% share price drop.
Although its price has dipped substantially, Intelligent Ultrasound Group may still be sending very bullish signals at the moment with its price-to-earnings (or "P/E") ratio of -12.3x, since almost half of all companies in the United Kingdom have P/E ratios greater than 15x and even P/E's higher than 29x are not unusual. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/E.
Intelligent Ultrasound Group certainly has been doing a good job lately as it's been growing earnings more than most other companies. It might be that many expect the strong earnings performance to degrade substantially, which has repressed the P/E. If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.
View our latest analysis for Intelligent Ultrasound Group
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Intelligent Ultrasound Group.How Is Intelligent Ultrasound Group's Growth Trending?
The only time you'd be truly comfortable seeing a P/E as depressed as Intelligent Ultrasound Group's is when the company's growth is on track to lag the market decidedly.
If we review the last year of earnings growth, the company posted a terrific increase of 19%. Still, EPS has barely risen at all from three years ago in total, which is not ideal. Therefore, it's fair to say that earnings growth has been inconsistent recently for the company.
Shifting to the future, estimates from the only analyst covering the company suggest earnings should grow by 29% over the next year. With the market only predicted to deliver 7.6%, the company is positioned for a stronger earnings result.
With this information, we find it odd that Intelligent Ultrasound Group is trading at a P/E lower than the market. It looks like most investors are not convinced at all that the company can achieve future growth expectations.
What We Can Learn From Intelligent Ultrasound Group's P/E?
Shares in Intelligent Ultrasound Group have plummeted and its P/E is now low enough to touch the ground. It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.
Our examination of Intelligent Ultrasound Group's analyst forecasts revealed that its superior earnings outlook isn't contributing to its P/E anywhere near as much as we would have predicted. There could be some major unobserved threats to earnings preventing the P/E ratio from matching the positive outlook. At least price risks look to be very low, but investors seem to think future earnings could see a lot of volatility.
We don't want to rain on the parade too much, but we did also find 3 warning signs for Intelligent Ultrasound Group (1 can't be ignored!) that you need to be mindful of.
Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with a strong growth track record, trading on a low P/E.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About AIM:IUG
Intelligent Ultrasound Group
Through its subsidiaries, develops, markets, and distributes medical training simulators in the United Kingdom, North America, and internationally.
Adequate balance sheet very low.